Pure Global

Ketoacid Analogues Intradialytic Effect on Inflammation - Trial NCT06392516

Access comprehensive clinical trial information for NCT06392516 through Pure Global AI's free database. This phase not specified trial is sponsored by RSUP Fatmawati and is currently Not yet recruiting. The study focuses on Hemodialysis Complication. Target enrollment is 86 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06392516
Not yet recruiting
drug
Trial Details
ClinicalTrials.gov • NCT06392516
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ketoacid Analogues Intradialytic Effect on Inflammation
Effect of Intradialytic Administration of Ketoacid Analogues on Inflammatory Parameters in Patients Undergoing Chronic Hemodialysis Twice a Week

Study Focus

Hemodialysis Complication

Ketoacid

Interventional

drug

Sponsor & Location

RSUP Fatmawati

Jakarta, Indonesia

Timeline & Enrollment

N/A

Apr 29, 2024

Sep 30, 2024

86 participants

Primary Outcome

interleukin-6,malnutrition inflammation score,neutrophil lymphocyte ratio,monocyte lymphocyte ratio,thrombocyte lymphocyte ratio

Summary

this study tries to measure the effect of intradialytic ketoacid analogues on inflammatory
 parameters

ICD-10 Classifications

Kidney dialysis
Other dialysis
Care involving dialysis
Mechanical complication of vascular dialysis catheter
Haemoglobinuria due to haemolysis from other external causes

Data Source

ClinicalTrials.gov

NCT06392516

Non-Device Trial